These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients. Takatsuki M, Chen CL, Chen YS, Wang CC, Lin CC, Yang CH, Yong CC, Liu YW. Clin Transplant; 2004 Dec; 18(6):694-9. PubMed ID: 15516246 [Abstract] [Full Text] [Related]
26. History of C2 monitoring in heart and liver transplant patients treated with cyclosporine microemulsion. Cantarovich M, Barkun J, Giannetti N, Cecere R, Besner JG, Tchervenkov J. Transplant Proc; 2004 Mar; 36(2 Suppl):442S-447S. PubMed ID: 15041383 [Abstract] [Full Text] [Related]
29. [C0 vs C2 levels and their implications in kidney transplantation]. Cuero C, Delgado E, de González M, Medina C, Vernaza A, Moscoso J. Rev Med Panama; 2002 Dec; 27():30-3. PubMed ID: 16737196 [Abstract] [Full Text] [Related]
31. Cyclosporine dose reduction in stable renal transplant patients with high C2 level: simplified method of single C2 measurement and individualization of C0 target. Higgins RM, Kanji H, Hernon M, Harrison P, Lam FT, Kashi SH. Transpl Int; 2005 Jul; 18(7):806-10. PubMed ID: 15948859 [Abstract] [Full Text] [Related]
37. Target range maximum of cyclosporine blood concentration two hours post dose in stable liver transplant patients. Li J, Dahmen U, Beckebaum S, Cicinnati V, Valentin-Gamazo C, Frilling A, Malago M, Broelsch CE. Eur J Med Res; 2006 Apr 28; 11(4):139-45. PubMed ID: 16720277 [Abstract] [Full Text] [Related]